First Time Loading...

Amphastar Pharmaceuticals Inc
NASDAQ:AMPH

Watchlist Manager
Amphastar Pharmaceuticals Inc Logo
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Watchlist
Price: 41.11 USD 0.69% Market Closed
Updated: Apr 29, 2024
AMPH
/
Income Statement
/
Revenue

Amphastar Pharmaceuticals Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amphastar Pharmaceuticals Inc
Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Revenue
$644.4m
CAGR 3-Years
23%
CAGR 5-Years
17%
CAGR 10-Years
11%
Johnson & Johnson
NYSE:JNJ
Revenue
$81.8B
CAGR 3-Years
-1%
CAGR 5-Years
0%
CAGR 10-Years
1%
Bristol-Myers Squibb Co
NYSE:BMY
Revenue
$45B
CAGR 3-Years
2%
CAGR 5-Years
15%
CAGR 10-Years
11%
Pfizer Inc
NYSE:PFE
Revenue
$58.5B
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Revenue
$60.1B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Revenue
$34.1B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
4%

Amphastar Pharmaceuticals Inc
Revenue Breakdown

Breakdown by Geography
Amphastar Pharmaceuticals Inc

Total Revenue: 644.4m USD
100%
United States: 635.2m USD
98.6%
France: 4.7m USD
0.7%
China: 4.5m USD
0.7%

Breakdown by Segments
Amphastar Pharmaceuticals Inc

Total Revenue: 644.4m USD
100%
Represents The Finished Pharmaceutical Produc...: 630.3m USD
97.8%
Product Revenues, Net: 593.2m USD
92.1%
Other Revenues: 51.2m USD
7.9%
Represents The Active Pharmaceutical Ingredie...: 14.1m USD
2.2%
Services For Research And Development: 4.5m USD
0.7%
Show More
Show Less

See Also

What is Amphastar Pharmaceuticals Inc's Revenue?
Revenue
644.4m USD

Based on the financial report for Dec 31, 2023, Amphastar Pharmaceuticals Inc's Revenue amounts to 644.4m USD.

What is Amphastar Pharmaceuticals Inc's Revenue growth rate?
Revenue CAGR 10Y
11%

Over the last year, the Revenue growth was 29%. The average annual Revenue growth rates for Amphastar Pharmaceuticals Inc have been 23% over the past three years , 17% over the past five years , and 11% over the past ten years .

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.